Advertisement
Singapore markets close in 1 hour 23 minutes
  • Straits Times Index

    3,298.79
    +8.09 (+0.25%)
     
  • Nikkei

    38,179.46
    -49.65 (-0.13%)
     
  • Hang Seng

    19,114.30
    +150.62 (+0.79%)
     
  • FTSE 100

    8,439.27
    +5.51 (+0.07%)
     
  • Bitcoin USD

    61,563.19
    +863.95 (+1.42%)
     
  • CMC Crypto 200

    1,271.49
    +11.29 (+0.90%)
     
  • S&P 500

    5,222.68
    +94.89 (+1.85%)
     
  • Dow

    39,512.84
    +837.14 (+2.16%)
     
  • Nasdaq

    16,340.87
    +184.57 (+1.14%)
     
  • Gold

    2,357.40
    -17.60 (-0.74%)
     
  • Crude Oil

    78.34
    +0.08 (+0.10%)
     
  • 10-Yr Bond

    4.5040
    +0.0040 (+0.09%)
     
  • FTSE Bursa Malaysia

    1,603.14
    +2.47 (+0.15%)
     
  • Jakarta Composite Index

    7,100.59
    +11.79 (+0.17%)
     
  • PSE Index

    6,604.25
    +92.32 (+1.42%)
     

Is CRISPR Therapeutics a Good Stock to Buy Following Approval of Its First Drug?

Is CRISPR Therapeutics a Good Stock to Buy Following Approval of Its First Drug?

A simultaneous pair of approvals from the U.S. Food and Drug Administration gives investors new factors to consider.